StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ARVEE.NS$160.00+3.25%
Fair $160.00+0.0%

ARVEE.NS

Arvee Laboratories (India) Ltd.

Basic Materials / Specialty ChemicalsNSE

$160.00

+5.20 (+3.25%)

Fairly Valued+0.0%Fair Value $160.00Fund rank 26/100 · Data gapFallback financials|
SA 47/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $10.8M · quality 44.0/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

47/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · ARVEE.NSLocal privado en este navegador · Arvee Laboratories (India) Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.8B

P/E

85.1x

↑

EV/EBITDA

42.5x

↑

ROE

6.9%

↑

Gross Margin

35.1%

↑

Debt/Equity

0.03

↓
52-Week Range$160
$129$291

TradingView lightweight chart

ARVEE.NS price, volumen y niveles de valoración

Último $165.23Periodo +428.7%
Fair value: $160.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-1.1%

FCF CAGR

—

FCF margin

-5.4%

FCF / Net income

-0.96x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $384.4M · net income $21.5M · FCF $-20.6M

2022-FY → 2025-FY

Gross margin

35.1%+0.4% pts

Operating margin

6.4%-1.2% pts

Net margin

5.6%-0.9% pts

FCF margin

-5.4%-1.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$384.4M$384.4M$303.4M$612.8M$396.9M
Net Income$21.5M$21.5M$10.5M$41.2M$25.7M
EBITDA$41.7M$41.7M$35.2M$85.3M$61.5M
EPS1.951.950.953.742.34
Gross Margin35.1%35.1%38.2%28.2%34.8%
Operating Margin6.4%6.4%4.9%8.6%7.6%
Net Margin5.6%5.6%3.5%6.7%6.5%
Balance Sheet
Debt/Equity0.030.030.030.040.13
Current Ratio3.353.35———
Cash Flow
Free Cash Flow$-20.6M$-20.6M$10.8M$14.4M$-16.8M
Returns
ROE6.9%6.9%3.6%14.7%10.8%
Valuation
P/E85.1185.11222.3725.8749.53
EV/EBITDA42.4642.4665.9612.5521.08
P/B5.645.648.003.805.33
Growth & Yield
Revenue Growth26.7%26.7%-50.5%54.4%—
EPS Growth105.3%105.3%-74.6%59.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

93.8%

muy exigente

EPS terminal req.

$14.20

Spread vs growth

11.4%

5Y implied EPS CAGR

54.5%

muy exigente

EPS terminal req.

$17.18

Spread vs growth

50.7%

10Y implied EPS CAGR

30.4%

muy exigente

EPS terminal req.

$27.67

Spread vs growth

74.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +6.5%

Total return

+6.5%

Start / end P/E

163.4x → 84.7x

EPS bridge

0.95 → 1.95

Residual

-50.7%

EPS growth+105.3%
Multiple rerating-48.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term-50.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.